Streetbeat News

Stock Prices

OBLG

Oblong, Inc. has regained compliance with Nasdaq's minimum bid price requirement after its stock traded above $1.00 for 10 consecutive days, resolving the issue with Nasdaq.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:11 pm

MNPR

Monopar Therapeutics shares rise following positive early data from its Phase 1 clinical trial, demonstrating MNPR-101-Zr's tumor targeting ability in humans.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:07 pm

ROKU

Roku shares rise following an upgrade by Wolfe Research from Peer Perform to Outperform, with a new price target of $93.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:05 pm

GRRR

Gorilla Technology Group Inc. (NASDAQ:GRRR) has announced a share buyback program of up to $6 million to address the sharp decline in its market cap from $650 million to $35 million. The company plans to repurchase 1.1 million shares within the next five business days, aiming to realign its stock price with its intrinsic value.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:05 pm

MNPR

Monopar Therapeutics has released early human clinical data from its ongoing open-label Phase 1 imaging and dosimetry study of MNPR-101-Zr. This study is crucial for understanding the potential of MNPR-101-Zr in medical imaging.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:05 pm

STSS

Sharps Technology has received approval from Nasdaq to maintain its listing, contingent on completing a reverse stock split to address a bid price deficiency. The company plans to execute the reverse split following an exception from the Nasdaq Hearings Panel.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:04 pm

ALK

ARKF

IPO

Alaska Air Group (NYSE:ALK) has raised its Q3 earnings forecast significantly, projecting adjusted EPS between $2.15 and $2.25, surpassing the analyst consensus of $1.60. This is attributed to strong summer travel demand and lower fuel costs. ALK shares rose 4.33% premarket.

Portfolio Pulse from Nabaparna Bhattacharya

September 12, 2024 | 12:02 pm

DXR

Daxor Corporation's blood volume analysis (BVA) technology has been highlighted in a review published in Cardiorenal Medicine. The review emphasizes BVA's role in improving care and outcomes for cardiorenal syndrome by enhancing precision in diuretic and red cell therapies, leading to more personalized treatment.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:02 pm

BGNE

CURV

OXM

PSNY

VNOM

Oxford Industries reported weaker-than-expected Q2 earnings and sales, leading to a 10.3% drop in pre-market trading. The company missed analyst estimates and provided FY24 guidance below expectations. Other stocks like GameStop, BeiGene, and Viper Energy also saw declines in pre-market trading.

Portfolio Pulse from Avi Kapoor

September 12, 2024 | 12:02 pm

MTSI

Analysts have provided a range of ratings for MACOM Technology Solutions (NASDAQ:MTSI), with a majority being bullish. The average 12-month price target has increased by 6.62% to $120.83. Despite positive revenue growth, the company faces challenges with profitability and debt management.

Portfolio Pulse from Benzinga Insights

September 12, 2024 | 12:01 pm